Monthly Adam & Eve Breakout Being Re-tested

dudebruhwhoa Updated   
BINANCE:HBARUSD   Hedera Hashgraph
Monthly close is in a little over 5 days. HBARUSD formed an Adam and Eve double-bottom on the monthly right at center and top of Monthly Support before breaking out to confirm that pattern and is now re-testing it for final confirmation or denial.

Hold the monthly neckline at 7.3 cents and we can expect a move up towards Monthly Resistance as we get into February and March.

Lose it and we likely will see another test of monthly support instead, which is around a falling wedge top, or this re-test area and/or the 200 day EMA and MA that I have marked and displayed on my weekly chart below.

Note that HBAR also saw a 50/200 day EMA and MA Golden Cross during the last few months of 2023, and is presently sitting back below the 50 EMA and MA. However, it has held above the 200 EMA and MA. So, we also need to see it recover the 50 EMA and MA if and after we see a close above the monthly neckline as well or these areas could be tested again.

Weekly chart showing Golden Crosses and Falling Wedge break / re-test(s) - also shown in related published ideas below, but updated chart pic here:

TL / DR - hold the Adam/Eve double-bottom's monthly neck @ 7.3 cents to continue up, lose it to re-test 200 day EMA/MA and/or the falling wedge re-test area marked on the weekly chart above.
Trade active:
Monthly close is in a little over 2 days, meanwhile the daily looks like it may drop and re-test some old trends around 5.8 or 5.1ish, or possibly a cent higher around the 200 day EMA or MA:

Here's the 200 day EMA and MA and a zoom out of those trends it could re-test if it loses the 200 EMA/MA:

Monthly closed below the neckline. Will likely see a re-test of the areas mentioned above, around 5.8, possibly 5.1 as well. Or, the 200 day EMA and MA which are presently sitting in the 6 cent range
Trade active:
Monthly closed below the neck but this may have just been a pullback as it has recovered that area quickly:


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.